Literature DB >> 25527690

Varicella zoster virus encephalomyelitis as a late complication following haematopoietic stem cell transplantation.

Lokesh Shahani1.   

Abstract

Varicella zoster virus (VZV) causes the primary infection manifesting as varicella or chickenpox, with possibility of reactivation later in life. A 71-year-old man presented with headache and lower extremity weakness. There was no evidence of skin lesions to suggest a recent zoster infection. The patient had a history of multiple myeloma diagnosed 2 years earlier, treated with chemotherapy and autologous stem cell transplant. Antimicrobial prophylaxis was discontinued 12 months after the transplant. MRI of the brain demonstrated areas of T2/fluid-attenuated inversion recovery hyperintensity in bilateral cerebral white matter and MRI of the spine demonstrated enhancement along the cauda equine. Cerebrospinal fluid (CSF) analysis showed lymphocytic pleocytosis and VZV DNA was detected by PCR in the CSF. The patient was treated with 8 weeks of antiviral therapy with complete resolution of symptoms. VZV should be considered in patients with haematopoietic stem cell transplantation presenting with similar neurological manifestations even in the absence of dermatological signs. 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25527690      PMCID: PMC4275714          DOI: 10.1136/bcr-2014-208540

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  15 in total

1.  Pre-eruptive varicella zoster virus encephalitis in two children after haematopoietic stem cell transplantation.

Authors:  Tobias Tenenbaum; Christof Maria Kramm; Hans-Jürgen Laws; Wenzel Nürnberger; Hans-Gerd Lenard; Ulrich Göbel
Journal:  Med Pediatr Oncol       Date:  2002-04

Review 2.  Varicella-Zoster virus: pathogenesis, immunity, and clinical management in hematopoietic cell transplant recipients.

Authors:  A M Arvin
Journal:  Biol Blood Marrow Transplant       Date:  2000       Impact factor: 5.742

3.  Varicella in Americans from NHANES III: implications for control through routine immunization.

Authors:  Paul E Kilgore; Deanna Kruszon-Moran; Jane F Seward; Aisha Jumaan; Frederik P L Van Loon; Bagher Forghani; Geraldine M McQuillan; Melinda Wharton; Laura J Fehrs; Cynthia K Cossen; Stephen C Hadler
Journal:  J Med Virol       Date:  2003       Impact factor: 2.327

Review 4.  Varicella and herpes zoster. Changing concepts of the natural history, control, and importance of a not-so-benign virus.

Authors:  T H Weller
Journal:  N Engl J Med       Date:  1983-12-08       Impact factor: 91.245

5.  Long-term acyclovir for prevention of varicella zoster virus disease after allogeneic hematopoietic cell transplantation--a randomized double-blind placebo-controlled study.

Authors:  Michael Boeckh; Hyung W Kim; Mary E D Flowers; Joel D Meyers; Raleigh A Bowden
Journal:  Blood       Date:  2005-11-10       Impact factor: 22.113

6.  [Varicella-zoster virus infection after hematopoietic stem cell transplantation].

Authors:  H Akiyama; T Inoue; Y Okoshi; S Mori; K Ohashi; Y Maeda; T Sasaki; Y Okuyama; K Hiruma; H Sakamaki
Journal:  Rinsho Ketsueki       Date:  2000-01

7.  Clinical features and risk factors for developing varicella zoster virus dissemination following hematopoietic stem cell transplantation.

Authors:  Y Umezawa; K Kakihana; G Oshikawa; T Kobayashi; N Doki; H Sakamaki; K Ohashi
Journal:  Transpl Infect Dis       Date:  2014-01-20       Impact factor: 2.228

8.  Infection with varicella-zoster virus after marrow transplantation.

Authors:  R M Locksley; N Flournoy; K M Sullivan; J D Meyers
Journal:  J Infect Dis       Date:  1985-12       Impact factor: 5.226

9.  One-year acyclovir prophylaxis for preventing varicella-zoster virus disease after hematopoietic cell transplantation: no evidence of rebound varicella-zoster virus disease after drug discontinuation.

Authors:  Veronique Erard; Katherine A Guthrie; Cara Varley; Judson Heugel; Anna Wald; Mary E D Flowers; Lawrence Corey; Michael Boeckh
Journal:  Blood       Date:  2007-05-21       Impact factor: 22.113

10.  The prophylactic role of intravenous and long-term oral acyclovir after allogeneic bone marrow transplantation.

Authors:  P J Selby; R L Powles; D Easton; T J Perren; K Stolle; B Jameson; A P Fiddian; Y Tryhorn; H Stern
Journal:  Br J Cancer       Date:  1989-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.